North America expected to dominate Needle Free Injection Systems market in 2016, with U.S. accounting for a major share. However, Europe is expected to grow at highest CAGR during forecast period. The high growth in this market is attributed to rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers & acquisitions by major companies in market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving market growth in Europe.
- Agency -.
Complete Report on Needle Free Injection Systems Market spread across 183 Pages, Profiling 12 Companies and Supported with 151 Tables and 33 Figures is now available at www.rnrmarketresearch.com/needle-f…arket-report.html .
Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.
- Needle-free Injection Manufacturers
- Needle-free Injection Instrument Manufacturers and Suppliers
- Research and Development Companies
- Medical Research Laboratories
- Academics Medical Centers and Universities
- Research and Consulting Firms
Needle free injection market segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and other end user.
- Agency -.
The growth in this segment can primarily be attributed to the advancement in the medication or drug delivery technology and rising geriatric population.
North America is poised to be fastest-growing region in the needle-free injection system market from 2016 to 2021. High growth in this market is attributed to factors such as the increasing demand for self-administration, and rising prevalence of chronic diseases and conditions (such as heart disease, stroke, cancer, type 2 diabetes, obesity, and arthritis), advantages offer by needle-free injection system are driving market growth.
Company Profiles (Overview, Products and Services, Financials, Strategy & Development)
1 Antares Pharma, Inc.
2 Endo International PLC
4 Bioject Medical Technologies Inc. (Acquired By Inovio Pharmaceuticals, Inc.)
5 Medical International Technology, Inc. (MIT)
6 Injex Pharma AG
7 National Medical Products, Inc.
8 Valeritas, Inc.
9 European Pharma Group
10 Penject Corporation
In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the needle-free injection system market. The report analyzes this market byproduct, technology, usability, site of delivery, type, applications, end user and region.
Comprehensive information on the product portfolios of the top players in the market-ray detectors market.
In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, and change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: